E7080, an oral multitargeted tyrosine kinase inhibitor, has direct anti-tumor efficacy via inhibition of KIT signaling in gastrointestinal stromal tumor (GIST)

被引：0

作者：

Yamamoto, Yuji ^{[1
]}

Watanabe, Tatsuo ^{[1
]}

Tsuruoka, Akihiko ^{[1
]}

Wakabayashi, Toshiaki ^{[1
]}

Asada, Makoto ^{[1
]}

机构：

[1] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4038

引用

页数：2

共 50 条

[1] Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor
George S.
[J]. Current Oncology Reports, 2007, 9 (4) : 323 - 327
[2] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
Glen, Hilary
Mason, Susan
Patel, Hitesh
Macleod, Kenneth
Brunton, Valerie G.
[J]. BMC CANCER, 2011, 11
[3] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in gastrointestinal stromal tumor (GIST) xenograft models
De Sutter, L.
Wozniak, A.
Verreet, J.
Vanleeuw, U.
De Cock, L.
Linde, N.
Drechsler, C.
Esdar, C.
Sciot, R.
Schoeffski, P.
[J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1239 - S1239
[4] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
Hilary Glen
Susan Mason
Hitesh Patel
Kenneth Macleod
Valerie G Brunton
[J]. BMC Cancer, 11
[5] Current management of patients with gastrointestinal stromal tumor receiving the multitargeted tyrosine kinase inhibitor sunitinib
Pilotte, Amy Potter
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (07) : 1363 - 1376
[6] Anti-tumor effects of the novel KIT mutant inhibitor M4205 in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
De Sutter, Luna
Wozniak, Agnieszka
Verreet, Jasper
Vanleeuw, Ulla
De Cock, Lore
Linde, Nina
Drechsler, Christine
Esdar, Christina
Sciot, Raf
Schoffski, Patrick
[J]. CANCER RESEARCH, 2022, 82 (12)
[7] Antitumor Effect of the Tyrosine Kinase Inhibitor Nilotinib on Gastrointestinal Stromal Tumor (GIST) and Imatinib-Resistant GIST Cells
Sako, Hiroyuki
Fukuda, Kazumasa
Saikawa, Yoshiro
Nakamura, Rieko
Takahashi, Tsunehiro
Wada, Norihito
Kawakubo, Hirohumi
Takeuchi, Hiroya
Ohmori, Tai
Kitagawa, Yuko
[J]. PLOS ONE, 2014, 9 (09):
[8] Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
Gebreyohannes, Yemarshet Kelemework
Van Looy, Thomas
Wozniak, Agnieszka
Wellens, Jasmien
Li, Haifu
Cornillie, Jasmien
Vanleeuw, Ulla
Vreys, Lise
Squires, Matthew
Rodringuez, Ana-Maria
Debiec-Rychter, Maria
Sciot, Raf
Schoffski, Patrick
[J]. CANCER RESEARCH, 2015, 75
[9] Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib
Saylor, Philip J.
Reid, Tony R.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3544 - 3546
[10] Preclinical development of a novel oral multitargeted kinase inhibitor with potent in vivo anti-tumor activity
Beaulieu, Normand
Dupont, Isabelle
Hannah Nguyen
Carole, Beaulieu
Ste-Croix, Helene
Robert, Marie-France
Lefebvre, Sylvain
Lu, Ai Hua
Dubay, Maria
Rahil, Gabi
Wang, James
Mannion, Michael
Raeppel, Stephane
Saavedra, Oscar
Claridge, Stephen
Isakovic, Lubo
Zhan, Lijie
Gaudette, Frederic
Zhou, Nancy
Nantel, Miguel
Raeppel, Franck
Vaisburg, Arkadii
Besterman, Jeffrey
Maroun, Christiane
[J]. CANCER RESEARCH, 2009, 69

← 1 2 3 4 5 →